Synthesis and Structural Studies of Three Uracil Derivatives, Methyl 3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanate, Methyl 3-(5-Nitro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanoate and Ethyl 3-(5-Nitro-2,4-dioxo-3,4-dihydropyrimidin-1 (2H)-yl)propanoate

被引:0
作者
Liu, Wuqiang [1 ]
Feng, Xiaogang [1 ]
Tao, Yangyang [1 ]
Zhou, Zheng [1 ]
Wu, Guanghui [1 ]
Xiong, Jing [1 ]
机构
[1] Wenzhou Univ, Coll Chem & Mat Engn, Wenzhou 325035, Peoples R China
关键词
Methyl 3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanoate; Methyl 3-(5-nitro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanoate; Ethyl 3-(5-nitro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)propanoate; Crystal structure; NMR spectra; FUNDAMENTAL FREQUENCIES; POTENT INHIBITORS; RAMAN-SPECTRA; IN-VITRO; 5-CHLOROURACIL; 5-FLUOROURACIL; MICHAEL; DESIGN; FTIR;
D O I
10.1007/s10870-014-0554-y
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
Three uracil derivatives of methyl 3-(2,4-dioxo-3,4- dihydropyrimidin-1(2H)-yl) propanoate (I), methyl 3-(5-nitro- 2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl) propanoate (II) and ethyl 3-(5-nitro-2,4-dioxo-3,4-dihydropyrimidin-1 (2H)-yl) propanoate (III) have been prepared through one pot synthesis and examined by X-ray crystallography, FT-IR and NMR spectroscopy. Compound I, C8H10N2O4, is monoclinic with space group P 21/c and cell constants a = 11.4437(12), b = 11.7980(13), c = 6.9496(7) angstrom, beta = 103.180(2)degrees, V = 913.57(17) angstrom(3), and Z = 4. Compound II, C8H9N3O6, crystallizes in the monoclinic P 21 space group with cell constants a = 8.0342(14), b = 5.7155(10), c = 11.572(2) angstrom, beta = 105.200(3)degrees, V = 512.79(16) angstrom(3), and Z = 2. Compound III, C9H11N3O6, is Orthorhombic with space group P 212121 and cell constants a = 5.7560(16), b = 8.032(2), c = 25.302(7) angstrom, beta = 90 degrees, V = 1169.8(6) angstrom(3), and Z = 4. The supramolecular architectures of the three compounds involve N-H center dot center dot center dot O hydrogen bond.
引用
收藏
页码:597 / 603
页数:7
相关论文
共 50 条
[31]   Synthesis, anticancer activity and molecular docking study of (E)-4-(3,4Dichlorophenyl)-2-((1,3-diphenyl-1H-pyrazol-4-yl)methylene)-3,4- dihydronaphthalen-1(2H)-one derivatives [J].
Sadanandam, Kudikala ;
Pinnoju, Prasad ;
Manasa, S. K. ;
Sarasija, Madderla .
CHEMICAL BIOLOGY LETTERS, 2024, 11 (01)
[32]   SYNTHESIS CHARACTERIZATION AND BIOLOGICAL EVALUATION OF NOVEL 1-(5-((3,5-DIMETHYL-4-((4-(TRIFLUOROMETHYL)PHENYL)DIAZENYL)-1H-PYRAZOL-1-YL)METHYL)-2-METHYL-2-PHENYL-1,3,4-OXADIAZOL-3(2H)-YL)ETHANONE [J].
Krishna, S. Murali ;
Babudr, P. Suresh ;
Abdulkalam, A. P. J. .
HETEROCYCLIC LETTERS, 2019, 9 (01) :101-108
[33]   Synthesis and antimicrobial activity of 2-substituted [4-(1,3,4-oxadiazol-2-yl methyl)] phthalazin-1(2H)-one derivatives [J].
Sridhara, Ajjanna M. ;
Reddy, Kallam R. Venugopala ;
Keshavayya, Jathi ;
Goud, Palusa Sanath Kumar ;
Somashekar, Bankavadi C. ;
Bose, Prosenjit ;
Peethambar, Sanenahalli K. ;
Gaddam, Satish Kumar .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (11) :4983-4989
[34]   Crystal structure of (Z)-ethyl 3-[2-(5methyl-7-nitro-1H-indole-2-carbonyl)hydrazinylidene] butanoate [J].
Errossafi, Amal ;
El Kihel, Abdellatif ;
Guesmi, Salaheddine ;
Saadi, Mohamed ;
El Ammari, Lahcen .
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2015, 71 :O684-+
[35]   Synthesis of new pyrimidine-containing compounds: 5-(2-(alkylamino)-1,3-dioxo-2,3-dihydro-1H-inden-2-yl)-6-hydroxypyrimidine-2,4(1H,3H)-dione derivatives [J].
Kochia, Khudaidad ;
Bayat, Mohammad ;
Nasri, Shima ;
Mohammadi, Aref .
MOLECULAR DIVERSITY, 2020, 24 (04) :1015-1024
[36]   Crystal structure of 2,6-bis(3-(pyrazin-2-yl)-1H-1,2,4-triazol-5-yl)pyridine-1-ethyl-3-methyl-1H-imidazol-3-ium bromide (1/1), C23H22N13Br [J].
Zhen, Zhiqiang .
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2018, 233 (01) :151-152
[37]   Synthesis and Cytostatic Activity of Substituted Derivatives of Sodium 1-Amino-2-cyano-1,6-dioxo-4-{[3-(ethoxycarbonyl)thiophen-2-yl]amino}hexa-2,4-dien-3-olates [J].
Gorbunova, I. A. ;
Mitusova, K. A. ;
Parkhoma, K. Yu. ;
Sharavyova, Yu. O. ;
Makhmudov, R. R. ;
Ustinova, O. Yu. ;
Denislamova, E. S. ;
Shipilovskikh, D. A. .
RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2024, 94 (12) :3140-3148
[38]   Synthesis and biological activity of heteroaryl 3-(1,1-dioxo-2H-(1,2,4)-benzothiadizin-3-yl)-4-hydroxy-2(1H)-quinolinone derivatives as hepatitis C virus NS5B polymerase inhibitors [J].
Tedesco, Rosanna ;
Chai, Deping ;
Darcy, Michael G. ;
Dhanak, Dashyant ;
Fitch, Duke M. ;
Gates, Adam ;
Johnston, Victor K. ;
Keenan, Richard M. ;
Lin-Goerke, Juili ;
Sarisky, Robert T. ;
Shaw, Antony N. ;
Valko, Klara L. ;
Wiggall, Kenneth J. ;
Zimmerman, Michael N. ;
Duffy, Kevin J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) :4354-4358
[39]   Synthesis, Biological Activity, and Computational Study of 1-[5-(4-Methylthiazol-5-yl)-2-phenyl-1,3,4-oxadiazol-3(2H)-yl]ethanone Derivatives [J].
Darekar, Nirmala R. ;
Takate, Sushama J. ;
Akolkar, Hemant N. ;
Shaikh, Mubarak H. ;
Khedkar, Vijay M. ;
Karale, Bhausaheb K. ;
Mhaske, Sadhana D. .
RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2022, 92 (08) :1511-1518
[40]   Synthesis and Biophysical Properties of Oligodeoxynucleotides Containing 2′-Deoxy-5-(4-nitro-1H-imidazol-1-yl)-β-D-uridine and 2′-Deoxy-5-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)-β-D-uridine Monomers [J].
Gondela, Andrzej ;
Kumar, Thatikonda Santhosh ;
Walczak, Krzysztof ;
Wengel, Jesper .
CHEMISTRY & BIODIVERSITY, 2010, 7 (02) :350-362